共 84 条
[1]
Antoniou A(2003)Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies Am J Hum Genet 72 1117-1130
[2]
Pharoah PDP(2007)Meta-analysis of BRCA1 and BRCA2 penetrance J Clin Oncol 25 1329-1333
[3]
Narod S(2015)A systematic comparison of traditional and multigene panel testing for hereditary breast and ovarian cancer genes in more than 1000 patients J Mol Diagn 17 533-544
[4]
Chen S(2015)Clinical actionability of multigene panel testing for hereditary breast and ovarian cancer risk assessment JAMA Oncol 1 943-951
[5]
Parmigiani G(2017)A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes Cancer 123 1721-1730
[6]
Lincoln SE(2017)The transfer of multigene panel testing for hereditary breast and ovarian cancer to healthcare: what are the implications for the management of patients and families? Oncotarget 8 1957-1971
[7]
Kobayashi Y(2014)Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes Eur J Hum Genet 22 1305-1313
[8]
Anderson MJ(2016)Frequency of germline mutations in 25 cancer susceptibility genes in a sequential series of patients with breast cancer J Clin Oncol 34 1460-1468
[9]
Desmond A(2017)Associations between cancer predisposition testing panel genes and breast cancer JAMA Oncol 18 823-832
[10]
Kurian AW(2016)Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing Genet Med 18 1-8